News Focus
News Focus
Post# of 198625
Next 10
Followers 42
Posts 9162
Boards Moderated 2
Alias Born 09/06/2014

Re: Grig81 post# 177748

Sunday, 07/28/2024 5:44:51 PM

Sunday, July 28, 2024 5:44:51 PM

Post# of 198625
IDE "Approval with Conditions" is still Approval and allows the company to proceed with human trials.

Unfortunately, the Great Unwashed OTC "investors" might not understand that "Approval With Conditions" is still Approval. We just have to roll with the punches in the OTC.

"Disapproval" is unlikely here, but even then it's just a delay, IMO, because if the FDA says "Disapproval" now they will eventually approve the IDE after more discussions. The FDA has already put the company through the wringer, especially with that earlier rejection of the Breakthrough Device Designation. Hubris has been punished; the FDA got their pound of flesh; now everyone, including the Mayo Clinic and the FDA, wants human trials to commence.

Ahhhh the OTC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News